Moreover, in the oligodendroglioma group, a correlation between INTS9 and the tumor proliferative stem cell component was only observed in primary tumors, not recurrences, possibly due to the limited sample size (n = 10) and significant tumor heterogeneity. The gene discussed is INTS9; the disease is neoplasm.